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PCLINICAL RESEARCH Vascular Disease
Arterial Reactivity in Lower
Extremities Is Progressively Reduced
as Cardiovascular Risk Factors Increase
Comparison With Upper Extremities Using Magnetic Resonance Imaging
Harry A. Silber, MD, PHD,* Joao A. C. Lima, MD, FACC,*† David A. Bluemke, MD, PHD,†
Brad C. Astor, PHD,‡ Sandeep N. Gupta, PHD,§ Thomas K. Foo, PHD,§
Pamela Ouyang, MD, FACC*
Baltimore, Maryland; and Milwaukee, Wisconsin
Objectives Our goal was to investigate whether the association between established cardiovascular risk factors and arterial
reactivity differs between the lower and upper extremities.
Background Resistance artery reactivity in the arm is associated with cardiovascular risk factors, coronary disease, and
events. However, the relationship of lower versus upper extremity vasoreactivity to increasing cardiovascular risk
factors has not been determined.
Methods We studied 82 subjects in 3 groups: 33 young healthy (YH) (21 to 41 years), 30 older healthy (OH) (50 years),
and 19 older type 2 diabetic subjects (OD). We directly measured systolic shear rate, flow, and radius in brachial
and femoral arteries at rest and during post-occlusion hyperemia using magnetic resonance imaging.
Results Brachial and femoral systolic shear rate, flow, and radius were similar among the groups at rest. Brachial hyper-
emic shear rate and hyperemic flow normalized as a function of baseline radius were not statistically different
when YH were compared with OH and OH with OD. In contrast, femoral hyperemic shear rate and hyperemic
flow normalized to baseline radius were lower in OH than YH (680  236 s1 vs. 843  157 s1, p  0.001,
and 0.84  0.25 mm1.27/s vs. 1.01  0.16 mm1.27/s, p  0.001) and lower in OD than OH (549  183 s1,
p  0.02, and 0.74  0.19 mm1.27/s, p  0.046).
Conclusions Persons with increasing cardiovascular risk factor burden had progressively reduced arterial reactivity in lower
but not upper extremities. This may help to explain why atherosclerosis usually develops more severely in legs
than in arms, and suggests that legs may be more sensitive than arms for assessing early global atherosclerotic
risk. (J Am Coll Cardiol 2007;49:939–45) © 2007 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.10.058a
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Hmproved methods are needed for predicting atherosclerosis
evelopment and cardiac events. Peripheral arterial reactiv-
ty noninvasively tests for nitric oxide-dependent endothe-
ial dysfunction, a key early event in atherosclerosis devel-
pment (1). Although the upper extremity is conveniently
vailable for testing arterial reactivity, there is evidence to
uggest that the lower extremity may be a more sensitive site
or assessing global cardiovascular risk. Atherosclerosis usu-
rom the *Department of Medicine, Division of Cardiology, and the †Department of
adiology, Johns Hopkins University School of Medicine, Baltimore, Maryland;
Johns Hopkins University School of Public Health, Baltimore, Maryland; and
General Electric Healthcare Technologies, Milwaukee, Wisconsin. This study was
upported by an NHLBI grant (K23 HL04477). Drs. Gupta and Foo were employed
y General Electric during this study. Michael O’Rourke, MD, DSc, FACC, served
s guest editor for this article.o
Manuscript received July 17, 2006; revised manuscript received October 20, 2006,
ccepted October 27, 2006.lly involves the lower extremities more severely than the
pper extremities (2), and endothelial function is more
mpaired in the lower than upper extremity in persons with
oronary artery disease (3). This suggests that endothelial
unction may be impaired earlier or more severely in lower
xtremities than upper extremities in persons with cardio-
ascular risk factors but without clinical coronary disease.
Certain tests of arterial reactivity are only partially de-
endent on nitric oxide, but this does not limit their ability
o identify groups at risk. The stimulus for flow-mediated
ilation (FMD) is post-occlusion hyperemic shear stress,
hich is hyperemic shear rate times viscosity (4–7). Hyper-
mic shear rate and flow are partially dependent on endo-
helial nitric oxide release from resistance arteries (8–10).
owever, the hyperemic response is also dependent on
ther molecular mechanisms, including prostaglandins
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Risk Factors and Leg and Arm Vasoreactivity by MRI March 6, 2007:939–45and adenosine (11). Although
hyperemic flow (HypQ) is only
partially regulated by endotheli-
ally released nitric oxide, reduced
hyperemia is associated with car-
diac risk factors, coronary artery
disease, and cardiac events (8,12–
17). This may be partly because
other properties that are associated
with cardiovascular risk factors, in-
cluding increased central arterial
tiffness, increased local arterial stiffness, and increased sympa-
hetic nervous system activity, are also associated with reduced
yperemic shear or flow (18–20). Indeed, a large study showed
hat the association between impaired FMD and cardiovascu-
ar risk factors was attributable to a reduced hyperemic shear
timulus for FMD (13).
Relatively greater reductions in lower compared with upper
xtremity HypQ have been demonstrated in subjects with
ypercholesterolemia and in subjects with peripheral arterial
isease (21,22). However, regional differences in hyperemic
hear rate have not been studied in persons with risk factors.
We previously reported a method of directly measuring
yperemic systolic shear rate and hyperemic systolic flow in the
rachial and femoral arteries from velocity-encoded images
btained using magnetic resonance imaging (MRI) (23). The
urpose of this study was to determine if there are differences
n lower versus upper extremity hyperemic shear rate or flow
esponses with increasing cardiovascular risk factors.
ethods
tudy participants. Eighty-two subjects from 3 groups
ere studied: 1) 33 healthy young adults, ages 21 to 41 years
16 men, 17 women), with no cardiovascular risk factors of
ypertension, diabetes, hyperlipidemia, smoking, obesity, or
ardiac disease in a first-degree relative; 2) 30 older healthy
ubjects, ages 50 to 74 years (14 men, 16 women), with no
ther cardiovascular risk factors; and 3) 19 older subjects
ith type 2 diabetes, ages 51 to 69 years (14 men, 5
omen). Subjects had no acute illness or documented
ymptoms of intermittent claudication, and were not on
itrate medicine. The study protocol was approved by the
nstitutional Review Board at the Johns Hopkins School of
edicine. All subjects gave written informed consent.
tudy protocol. Subjects abstained from eating or drinking
xcept water for at least 6 h before the study. All scans were
erformed in the morning. Baseline blood pressure was
ecorded in the right arm. Phase-contrast MRI was per-
ormed as described previously (23), using a 1.5-T scanner
CV/i, General Electric Healthcare Technologies, Milwau-
ee, Wisconsin) equipped with cardiac gradient coils (40
T/m, 120 T/m/s). Electrocardiographic leads were placed
n the thorax. To image the brachial artery, a 3-inch
eceiver coil was placed medial to the upper arm. An
Abbreviations
and Acronyms
FMD  flow-mediated
dilation
HDL  high-density
lipoprotein
HypQ  hyperemic flow
MRI  magnetic resonance
imagingnflatable cuff was placed on the forearm, extending to just rbove the elbow. To image the femoral artery, a 4-element
hased array receiver coil was placed anterior and posterior
o the upper thigh. An inflatable cuff was placed on the lower
high. The cuff was inflated at least 30 mm Hg above the
ubject’s measured systolic blood pressure for 5 min, then
eleased. For each artery, phase-contrast images using the same
xed cross-sectional axial prescription were obtained before
nd immediately after cuff release. Serum values of glucose,
ematocrit, and fasting lipid panel were obtained in all
roups, and hemoglobin A1C in groups 2 and 3, after the
canning portion of the study.
maging protocol. Coronal and axial scout images were
btained to locate the brachial artery, to locate the superficial
emoral artery at 3 to 5 cm distal to the bifurcation of the
ommon femoral artery, and to verify that the arteries were
arallel to the magnet bore. Phase-contrast scans were gated to
he electrocardiogram signal. A single imaging plane perpen-
icular to the artery of interest was prescribed. The imaging
arameters were: matrix size 256  128, field-of-view 8  8
m for the brachial artery and 10  10 cm for the femoral
rtery, slice thickness 3 mm, flip angle 25°, bandwidth 31.2
Hz, repetition time 11.43 ms, echo time 5.25 ms, 8 views per
egment, first-order flow compensation, no phase-wrap, and
o magnitude weighting. Settings of 16 signal averages (NEX)
ere used at baseline, and 2 NEX after cuff release. During
eak hyperemia, 10 views per segment were used if necessary to
btain a scan time of 35 s or less. The velocity encoding
radient was 50 to 70 cm/s during baseline and 120 to 150
m/s during peak hyperemia. Resulting temporal resolution
as about 90 to 180 ms. Each scan provided 5 to 9 magnitude
anatomic) and phase (velocity) images of the arterial cross
ection during the cardiac cycle.
ata analysis. Image data was imported via Scion Image
Scion Corporation, Frederick, Maryland) into a spreadsheet-
ased (Excel, Microsoft Corporation, Mountain View, Cali-
ornia) program created in our laboratory. The program em-
loys a user-independent algorithm to measure arterial radius,
lood flow, and shear rate from the phase images. The
lgorithm located the precise center of the arterial cross section
s where the velocity datapoints in a radial plot were optimally
orrelated. An approach simplified from Oyre et al. (24) was
sed to calculate shear rate and radius. The cardiac phase
ontaining peak flow was used. A 1-mm wide segment of
elocity datapoints in the radial plot near the lumen wall was fit
y least-squares method to a parabola, with the assumption
hat blood flow velocity at the lumen wall is zero. The outer
dge of the segment was defined where a smoothed average of
he velocity profile decreased to 20% of the peak velocity in the
ross section. Systolic shear rate was calculated as the slope of
he best-fit parabola where the parabola equaled zero. The
istance from this point to the center was defined as the radius
f the artery. Systolic flow was calculated by summing the
elocity pixels within the radius of the artery. This approach
rovided sub-pixel precision in determining shear rate and
adius.
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March 6, 2007:939–45 Risk Factors and Leg and Arm Vasoreactivity by MRIWe previously showed in young healthy subjects that
ypQ is strongly related to baseline radius squared when
he brachial and femoral arteries are considered together
23). To compare HypQ between arm and leg, we normal-
zed HypQ by dividing it by a function of baseline radius
erived for the brachial and femoral arteries separately. The
unction was derived in young healthy subjects using a
og-linear regression. For log (HypQ)  (a) log (baseline
adius)  b, this means that HypQ  (b)(baseline radius)a.
y design, HypQ normalized to baseline arterial radius
hould be close to 1 for both brachial and femoral arteries in
he young healthy group. Hyperemic flow being normalized
o baseline radius can be seen as a surrogate for normalizing
ypQ to limb volume, since arterial diameters grow in
roportion to volume of the downstream tissue (25).
tatistical analysis. Results are expressed as mean value 
D. Student t tests were used for pairwise comparisons
etween groups. Paired t tests were used to compare
easured parameters between baseline and hyperemia, and
o compare normalized HypQ between femoral and brachial
rteries. A p value 0.05 was considered significant.
esults
ubject characteristics. Subject characteristics are summa-
ized in Table 1. Compared with the younger healthy
ubjects, the older healthy subjects had higher body mass
ndex, systolic blood pressure, fasting glucose (although still
ithin the normal range), total cholesterol, and low-density
ipoprotein, but they had greater high-density lipoprotein
HDL). Compared with the older healthy subjects, the older
iabetic subjects had greater body mass index, systolic blood
ressure, fasting glucose, triglycerides, hemoglobin A1C, and
ower HDL. Only the diabetic subjects were on vasoactive
edications. Of the 19 older diabetic subjects studied, 9 (47%)
ere on angiotensin-converting enzyme inhibitors, 2 (11%)
ere on angiotensin receptor antagonists, 2 (11%) were on
alcium-channel blockers, 2 (11%) were on beta-blockers, and
Clinical Characteristics of the Study Population
Table 1 Clinical Characteristics of the Stud
Subject Characteristics YH
Number of subjects (male/female) 33 (16/17)
Age, yrs 26 5
Body mass index 23 3
Systolic blood pressure, mm Hg 111 11
Diastolic blood pressure, mm Hg 70 7
Glucose, mg/dl 81 9
Cholesterol, mg/dl 172 31
Triglycerides, mg/dl 85 33
High-density lipoprotein, mg/dl 60 13
Low-density lipoprotein, mg/dl 94 28
Hematocrit, % 42.6 3.2
Hemoglobin A1C, % —Data are expressed as mean  SD.
OD  older diabetic; OH  older healthy; YH  young healthy.2 (63%) were on statins. One subject was on a nitrate, which
as held for 24 h before the scan.
RI data analysis. Figure 1 shows the phase image
btained of typical brachial and femoral and arterial cross
ections during systole at baseline. Beside each image is a
adial plot of the datapoints. Each plot shows the best-fit
arabola segment and measured shear rate. Figure 2 illus-
rates radial plots of velocity data during systole in the
rachial and femoral arteries of a typical young control
ubject at baseline and during peak hyperemia. Systolic
hear rate increased substantially during peak hyperemia.
The relationship between hyperemic systolic flow
HypQ) and baseline radius (R) was:
ypQ brach
 140Rbrach
1.07 in brachial arteries of young healthy subjects
(p 0.0001, r 0.84 for log [HypQ brach] vs. log [Rbrach])
ypQ fem
 185 Rfem
1.73 in femoral arteries of young healthy subjects
(p 0.0001, r 0.80 for log [HypQ fem] vs. log [Rfem])
yperemic systolic flow in brachial arteries was normalized
or baseline radius:
HypQ brach ⁄ ([140][Rbrach
1.70 ])
yperemic systolic flow in femoral arteries was normalized
or baseline radius:
HypQ fem ⁄ ([185][Rfem
1.73])
agnetic resonance imaging-derived measurements are
ummarized in Table 2. The groups were similar at baseline
ith regard to brachial arterial radius, brachial systolic flow,
ulation
H OD
p Value,
YH vs. OH
p Value,
OH vs. OD
4/16) 19 (14/5)
6 61 6 0.0001 0.07
3 28 4 0.02 0.0003
11 134 15 0.007 0.0003
8 78 12 0.07 0.08
10 145 40 0.008 0.0001
28 192 56 0.0001 0.23
37 135 89 0.26 0.03
18 61 17 0.008 0.04
28 105 48 0.004 0.25
2.9 42.2 2.4 0.37 0.45
0.4 7.5 1.2 — 0.0001y Pop
O
30 (1
58
24
118
73
87
202
91
70
114
42.3
5.7
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Risk Factors and Leg and Arm Vasoreactivity by MRI March 6, 2007:939–45rachial systolic shear rate, femoral arterial radius, femoral
ystolic flow, and femoral systolic shear rate.
yperemic shear rate. Brachial hyperemic systolic shear rate
ended to be lower in older healthy subjects than young healthy
ubjects (996  305 s1 vs. 1,041  280 s1, p  0.28), and
ended to be lower in older diabetic than older healthy subjects
909  246 s1 vs. 996  305 s1, p  0.26); however, the
roups were not statistically significantly different. In contrast,
emoral hyperemic systolic shear rate was significantly lower in
lder healthy than young healthy subjects (680  236 s1 vs.
43 157 s1, p 0.001), and was significantly lower in older
iabetic than older healthy subjects (549  183 s1 vs. 680 
36 s1, p  0.02).
hange in shear rate from baseline to hyperemia.
hange in brachial systolic shear rate from baseline to
yperemia tended to be lower in older healthy subjects than
oung healthy subjects (572  196 s1 vs. 654  225 s1,
 0.06), and tended to be lower in older diabetic than
lder healthy subjects (530  176 s1 vs. 572  196 s1,
 0.40) (Fig. 3A), but the groups were not statistically
ignificantly different. In contrast, change in femoral systolic
hear rate from baseline to hyperemia was significantly
Figure 1 Analysis of Velocity-Encoded Images
Velocity-encoded image of brachial and femoral artery cross sections in a typi-
cal young, healthy subject during systole. To the right of each image is a plot
of the velocity datapoints (open circles) versus their distance from the optimal
center of the cross section. Each plot also shows the parabola segment that is
best fit to the datapoints near the arterial wall. The distance from the center at
which the best-fit parabola equals zero is the radius of the cross section. The
slope of the best-fit parabola at the radius of the cross section is shear rate.
Flow is the sum of the velocity points in the cross section.ower in older healthy subjects than young healthy subjects251  150 s1 vs. 450  120 s1, p  0.001), and was
ignificantly lower in older diabetic than older healthy subjects
150  142 s1 vs. 251  150 s1, p  0.01) (Fig. 3B).
ypQ normalized as a function of baseline arterial
adius. Hyperemic brachial flow normalized as a function of
rachial arterial radius was similar between older healthy and
oung healthy subjects (1.05  0.28 mm1.30/s vs. 1.02  0.19
m1.30/s, p  0.29), and was similar between older diabetic
nd older healthy subjects (1.05  0.22 mm1.30/s vs. 1.05 
.28 mm1.30/s, p 0.48). In contrast, hyperemic femoral flow
ormalized as a function of femoral arterial radius was signif-
cantly lower in older healthy than young healthy subjects
0.84  0.25 mm1.27/s vs. 1.01  0.16 mm1.27/s, p  0.001),
nd was lower in older diabetic than older healthy subjects
0.74  0.19 mm1.27/s vs. 0.84  0.25 mm1.27/s, p  0.046).
emoral normalized HypQ was similar to brachial normalized
ow in the young healthy group (1.01 0.16 mm1.27/s vs. 1.02
0.19 mm1.30/s, p  0.45); however, femoral normalized
ypQ was less than brachial normalized HypQ in the older
ealthy group (0.84 0.25 mm1.27/s vs. 1.05 0.28 mm1.30/s,
 0.0001) and in the older diabetic group (0.74  0.19
m1.27/s vs. 1.05  0.22 mm1.30/s, p  0.0001).
iscussion
he major finding of this study was that resistance artery
eactivity was progressively reduced in the lower extremity
Figure 2 Velocity Profiles at Baseline and During Hyperemia
Velocity profiles of the brachial and femoral arteries during systole at baseline
(left) and at peak hyperemia (right) for the same younger subject as in Figure
1. Also shown are the parabola segments that are best fit to the datapoints
near the arterial wall. Shear rate, the slope of the parabola segment near the
arterial wall, is increased significantly during hyperemia.
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March 6, 2007:939–45 Risk Factors and Leg and Arm Vasoreactivity by MRIut not the upper extremity as cardiovascular risk factors
ncreased. This suggests that measuring resistance artery
eactivity in the lower extremity may be more sensitive than
n the upper extremity for assessing global risk of athero-
clerotic cardiovascular disease. Also, to our knowledge, this
s the first study to measure hyperemic shear rate directly in
eripheral arteries of subjects with cardiovascular risk factors
nd to compare them with healthy subjects.
echanisms and risk associated with hyperemic shear
ate and flow. Post-occlusion hyperemic shear rate and flow
re partially dependent on endothelial nitric oxide release from
esistance arteries (8–10). However, the hyperemic response is
lso dependent on other molecular mechanisms, including
rostaglandins and adenosine (11). Nevertheless, reduced hy-
eremia is associated with cardiac risk factors, coronary artery
isease, and cardiac events (8,12–17). The reasons why hyper-
mic response identifies groups at risk despite being only
artially dependent on nitric oxide are not completely under-
tood. Possible explanations are that: 1) partial dependence on
itric oxide is sufficient to detect abnormalities that precede
vert atherosclerosis; or 2) additional mechanisms that are also
elated to cardiovascular risk underlie the hyperemic response.
e believe that the latter is most likely because several other
echanisms that are associated with risk factors are also
ssociated with reduced hyperemic shear or flow. These in-
lude increased central arterial stiffness, increased lower ex-
remity arterial stiffness, and increased sympathetic nervous
ystem activity (20,26). These processes promote or are mark-
rs for increased risk of global atherosclerosis or cardiac events
27–29), though they are not independent of endothelial
ysfunction (29,30). Taken together with our findings, this
MRI Measurements
Table 2 MRI Measurements
MRI Measurements
YH
n  33
Brachial artery at baseline
Radius, mm 2.15 0.41
Flow, ml/min 190 118
Shear rate, s1 386 123
Brachial artery at peak hyperemia
Flow, ml/min 514 177*
Normalized flow†, mm1.30/s 1.02 0.19
Shear rate, s1 1,041 280*
Change in shear rate from baseline, s1 654 225
Femoral artery at baseline
Radius, mm 3.53 0.43
Flow, ml/min 729 210
Shear rate, s1 393 79
Femoral artery at peak hyperemia
Flow, ml/min 1,684 437*
Normalized flow†, mm1.27/s 1.01 0.16
Shear rate, s1 843 157*
Change in shear rate from baseline, s1 450 120
Measurements were obtained during peak systole. Data are expresse
baseline radius by an exponential function (see text); ‡p  0.0001 fe
MRI  magnetic resonance imaging; other abbreviations as in Tabluggests that reduced hyperemic shear or flow in the lower vxtremity may be a sensitive integrated marker of cardiovascu-
ar risk.
omparison with other studies. We did not find differ-
nces in resting lower extremity shear rate, flow, or normal-
zed flow between groups, in contrast with one study (31),
ut in agreement with others (21,22,26,32–34). Other
tudies found no differences in forearm hyperemia with risk
actors (21,22,35), and also found that leg hyperemia may be
educed even when arm hyperemia is not (21,22). Also in
greement with our study, those studies showed that lower
xtremity HypQ measures compared with resting flow
easures more clearly distinguished groups with different
evels of risk (21,22). The insensitivity of brachial hyperemia
o risk factors in prior studies may relate to their measure-
ent of mean flow instead of systolic or diastolic hyperemic
hear, as suggested by Mitchell’s study of over 2,000 subjects
13). Our results do not necessarily conflict with that study,
ut rather suggest that a much smaller sample size may be
ufficient to demonstrate reduced lower extremity resistance
rtery reactivity in the presence of risk factors.
asoactive medications. Angiotensin-converting enzyme
nhibitors, angiotensin receptor antagonists, and statins
mprove endothelial function in the upper extremities of
ype 2 diabetic patients (36,37). Thus, hyperemic shear rate
as lowest in older diabetic patients despite their use of
edicines that improve endothelial function. Future studies
hould examine whether certain cardiovascular medicines
ffect vasoreactivity of lower extremity arteries differently
han upper extremities.
tudies of reproducibility. Reproducibility of post-
schemic hyperemic shear rate and flow measurements are
OH
n  30
OD
n  19
p Value,
YH vs. OH
p Value,
OH vs. OD
.24 0.37 2.51 2.37 0.19 0.33
22 105 264 97 0.13 0.17
24 147 378 136 0.14 0.18
86 229* 696 183* 0.09 0.11
.05 0.28 1.05 0.22 0.29 0.48
96 305* 909 246* 0.28 0.26
72 196 530 176 0.06 0.40
.63 0.49 3.86 0.57 0.22 0.10
16 205 884 205 0.06 0.34
29 124 399 100 0.07 0.17
47 99* 1,379 291* 0.02 0.25
.84 0.25‡ 0.74 0.19§ 0.001 0.046
80 236* 549 183* 0.001 0.02
51 150 150 142 0.0001 0.01
ean  SD. *p  0.0001 hyperemia versus baseline; †normalized to
ersus brachial artery; §p  0.0001 femoral versus brachial artery.2
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Risk Factors and Leg and Arm Vasoreactivity by MRI March 6, 2007:939–45ion strain-gauge plethysmography, or MRI (23,38,39).
ndeed, an ultrasound-based study found that reproducibil-
ty of brachial HypQ was better than that of FMD mea-
urements (38). This enhances the potential utility of
easuring resistance artery reactivity for assessing cardio-
ascular risk.
ower versus upper extremity arteries. Recent studies
how that arterial reactivity may be more impaired in legs
han in arms in individuals with coronary artery disease or
eripheral arterial disease (3,21). Coronary artery disease
nd peripheral arterial disease have common risk factors.
he results of this study suggest that arterial dysfunction
ccurs earlier or more severely in lower than upper
xtremities of persons with risk factors but no overt
therosclerotic disease. Those studies, taken together
ith the results of our study, may help to explain why leg
rteries usually develop more severe atherosclerosis than
rachial arteries (2). Regional differences in arterial
unction may underlie regional differences in atheroscle-
Figure 3 Change in Shear Rate From Baseline to Hyperemia
(A) Brachial change in systolic shear rate from baseline to peak hyperemia in
the 3 groups: reduction with increasing risk factors was not statistically signifi-
cant. (B) Femoral change in systolic shear rate from baseline to peak hyper-
emia is progressively decreased as cardiovascular risk factors increase.
Horizontal bars represent mean  SD.otic development. wesistance and conduit arteries. This study examined va-
odilator functionof resistancearteries—themicrovasculature—
y examining flow and shear rate in upstream conduit
rteries, the brachial and femoral arteries. Future studies
hould investigate whether there are differences between
egs and arms in macrovascular function—FMD of conduit
rteries—in subjects with risk factors.
echnical considerations. Magnetic resonance imaging
as unique properties that compliment those of other
ethods in helping to understand certain aspects of vascular
eactivity. Magnetic resonance imaging acquires the entire
ow velocity profile within a cross section and is thus
dvantageous for directly measuring shear rate. For imaging
he femoral artery, clothing and the depth of the artery are
ot barriers to MRI. Limitations of MRI compared with
ltrasound include temporal and spatial resolution, expense,
nd lack of portability.
Regarding temporal resolution, the precise point of peak
ystolic flow within the cardiac cycle may have been missed
lightly, thus the measured systolic shear rate and flow values
ay be slightly less than the true maximum systolic values. In
ddition, the magnetic resonance image acquisition begun
mmediately after cuff release was approximately 30 s in
uration, although the primary data contributing to image
ormation was acquired at 15 s (middle of k-space) for the
agnetic resonance pulse sequence used. A study by Leeson et
l. (40) using ultrasound showed that brachial HypQ at 15 s
fter cuff release was not substantially decreased from 5 s after
uff release for a 4.5-min cuff occlusion duration. Nevertheless,
ystolic HypQ or shear rate could possibly be less sensitive to
isk factors by magnetic resonance than by ultrasound. In any
ase, the increased sensitivity of femoral versus brachial mea-
urements in distinguishing at-risk groups is unlikely to be an
rtifact of magnetic resonance properties. Our findings of
ncreased sensitivity of the leg arteries to risk factors should be
onfirmed with ultrasound. A more accessible leg artery for
ltrasound scanning, such as the popliteal artery, may provide
imilar sensitivity to the femoral artery.
tudy limitations. The multiple statistical tests conducted,
8 in Table 2, increase the potential for significant findings by
hance. Another limitation due to sample size is that the
elative contribution of specific risk factors to decreased resis-
ance artery reactivity could not be determined. However,
uture studies may be able to assess the relative importance of
pecific risk factors on leg artery reactivity with a smaller
ample size than would be required if the arm were studied.
lso, we did not investigate subjects with established athero-
clerosis, which future studies should include.
onclusions
rterial reactivity in the lower but not upper extremity was
rogressively reduced with increasing cardiovascular risk fac-
ors. This implies early or more severe impairment of resistance
rtery vasodilator function in the lower extremities of persons
ith risk factors, and may help to explain why atherosclerosis
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pper extremities. Further, the findings suggest that resistance
rtery vasodilator activity may be a more sensitive indicator of
lobal cardiovascular risk in the leg than the arm.
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